Nick Ede
Chief Tech/Sci/R&D Officer at IMUGENE LIMITED
Net worth: 1 M $ as of 2024-03-30
Profile
Nicholas Ede is currently the Director at Eden Peptide Pty Ltd.
and the Chief Technology Officer at Imugene Ltd.
He previously served as the Chief Executive Officer at Mimotopes Pty Ltd.
from 2006 to 2010 and at Adistem Pty Ltd.
from 2010 to 2011.
He also held the position of Director at Mimotopes Pty Ltd.
and Chief Operating Officer at Equatorial Coal Ltd.
Additionally, he was the Chief Technology Officer at Rhinomed Ltd.
from 2012 to 2013 and the Vice President-Chemistry at Novartis Australia Pty Ltd.
Dr. Ede obtained a doctorate degree from Monash University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
IMUGENE LTD
0.24% | 2023-08-25 | 17,600,000 ( 0.24% ) | 1 M $ | 2024-03-30 |
Nick Ede active positions
Companies | Position | Start |
---|---|---|
IMUGENE LIMITED | Chief Tech/Sci/R&D Officer | 2013-02-10 |
Eden Peptide Pty Ltd. | Director/Board Member | - |
Former positions of Nick Ede
Companies | Position | End |
---|---|---|
RHINOMED | Chief Tech/Sci/R&D Officer | 2013-01-23 |
Adistem Pty Ltd. | Chief Executive Officer | 2011-09-30 |
Equatorial Coal Ltd.
Equatorial Coal Ltd. CoalEnergy Minerals Equatorial Coal Ltd. explores and operates coal and biotechnology research in Indonesia. The company's subsidiaries include ImmunoTX Pty Ltd and Titan Resources Pte. Ltd. Equatorial is headquartered in West Perth. Australia. | Chief Operating Officer | 2010-08-25 |
Mimotopes Pty Ltd.
Mimotopes Pty Ltd. Pharmaceuticals: OtherHealth Technology Mimotopes Pty Ltd is an industry leader in the peptide and discovery chemistry sector. Mimotopes develops, markets and distributes high quality biochemical products and services for the life-science sector. Their customers range from small labs and universities worldwide, to large multinational drug discovery companies. Their core competence covers the following areas: ' Custom Peptides Mimotopes' custom peptides are synthesized in modern, automated synthesizers using advanced solid phase techniques. The value in using Mimotopes custom peptides is not only that they offer a wide range of peptide lengths, purities and quantities. Their customers can also draw on the exceptional experience of their technical staff, who consult with them to design the peptide application that gives the best possible research outcome. ' PepSets Peptide Libraries Peptide libraries for various screening applications in Proteomics, Immunology and Drug Discovery. PepSets peptide libraries provide researchers with a rapid and cost effective solution for an immense range of bioactivity screening purposes. These sets of custom synthesized peptides enable fast, efficient results. ' Peptide Reagents High-quality amino acids and peptide synthesis reagents. The same reagents that Mimotopes uses in its in-house production system. ' SynPhase Lanterns Modular solid phase supports for organic synthesis, combinatorial chemistry, peptide chemistry, molecule scavenging and affinity applications. Convenient to handle, SynPhase Lanterns are the unique and reliable alternative to using conventional resins for solid-phase synthetic chemistry. Not only do SynPhase Lanterns provide superior reaction kinetics, but their unrivalled ease of handling results in less errors, better traceability and ultimately, faster, more accurate results. | Chief Executive Officer | 2010-02-28 |
Novartis Australia Pty Ltd.
Novartis Australia Pty Ltd. BiotechnologyHealth Technology Novartis Australia Pty Ltd. engages in the marketing and wholesale of pharmaceutical products in Australia. The company is headquartered in North Ryde, Australia. | Corporate Officer/Principal | - |
Training of Nick Ede
Monash University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
RHINOMED | Health Technology |
IMUGENE LIMITED | Health Technology |
Private companies | 5 |
---|---|
Equatorial Coal Ltd.
Equatorial Coal Ltd. CoalEnergy Minerals Equatorial Coal Ltd. explores and operates coal and biotechnology research in Indonesia. The company's subsidiaries include ImmunoTX Pty Ltd and Titan Resources Pte. Ltd. Equatorial is headquartered in West Perth. Australia. | Energy Minerals |
Mimotopes Pty Ltd.
Mimotopes Pty Ltd. Pharmaceuticals: OtherHealth Technology Mimotopes Pty Ltd is an industry leader in the peptide and discovery chemistry sector. Mimotopes develops, markets and distributes high quality biochemical products and services for the life-science sector. Their customers range from small labs and universities worldwide, to large multinational drug discovery companies. Their core competence covers the following areas: ' Custom Peptides Mimotopes' custom peptides are synthesized in modern, automated synthesizers using advanced solid phase techniques. The value in using Mimotopes custom peptides is not only that they offer a wide range of peptide lengths, purities and quantities. Their customers can also draw on the exceptional experience of their technical staff, who consult with them to design the peptide application that gives the best possible research outcome. ' PepSets Peptide Libraries Peptide libraries for various screening applications in Proteomics, Immunology and Drug Discovery. PepSets peptide libraries provide researchers with a rapid and cost effective solution for an immense range of bioactivity screening purposes. These sets of custom synthesized peptides enable fast, efficient results. ' Peptide Reagents High-quality amino acids and peptide synthesis reagents. The same reagents that Mimotopes uses in its in-house production system. ' SynPhase Lanterns Modular solid phase supports for organic synthesis, combinatorial chemistry, peptide chemistry, molecule scavenging and affinity applications. Convenient to handle, SynPhase Lanterns are the unique and reliable alternative to using conventional resins for solid-phase synthetic chemistry. Not only do SynPhase Lanterns provide superior reaction kinetics, but their unrivalled ease of handling results in less errors, better traceability and ultimately, faster, more accurate results. | Health Technology |
Novartis Australia Pty Ltd.
Novartis Australia Pty Ltd. BiotechnologyHealth Technology Novartis Australia Pty Ltd. engages in the marketing and wholesale of pharmaceutical products in Australia. The company is headquartered in North Ryde, Australia. | Health Technology |
Adistem Pty Ltd. | |
Eden Peptide Pty Ltd. |
- Stock Market
- Insiders
- Nick Ede